Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

08 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/08/3308120/0/en/sparrow-pharmaceuticals-announces-phase-2a-data-showing-cardiometabolic-benefits-of-clofutriben-in-adults-with-type-2-diabetes.html

03 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/03/3306054/0/en/sparrow-pharmaceuticals-announces-acceptance-of-late-breaking-presentation-of-interim-part-1-results-from-captain-t2d-at-the-endocrine-society-endo-2026-annual-meeting.html

29 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/29/3303583/0/en/sparrow-pharmaceuticals-to-present-phase-2a-results-for-clofutriben-in-type-2-diabetes-at-the-2026-american-diabetes-association-ada-scientific-session.html

02 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/02/3230263/0/en/Sparrow-Appoints-Biopharmaceutical-Industry-Veteran-Carlo-Incerti-M-D-to-its-Board-of-Directors.html

06 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/06/3213533/0/en/Sparrow-Pharmaceuticals-Announces-First-Patient-Enrolled-in-Phase-2b-Clinical-Trial-Evaluating-Clofutriben-for-Difficult-to-Control-Type-2-Diabetes.html

24 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/24/3155451/0/en/Sparrow-Pharmaceuticals-Announces-95-Million-Series-B-Financing-to-Advance-Targeted-Therapy-for-Type-2-Diabetes.html
ABOUT THIS PAGE